Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 11Nasopharyngeal Carcinoma 7Melanoma 3Lung Neoplasms 3Esophageal Squamous Cell Carcinoma 3Colorectal Neoplasms 3Uterine Cervical Neoplasms 2Sarcoma 2Nasopharyngeal Neoplasms 2Lymphoma, T-Cell, Peripheral 2Lymphoma, T-Cell 2Esophageal Neoplasms 2Unresectable Non-small Cell Lung Cancer 1Small Cell Lung Carcinoma 1Recurrence 1Pleural Effusion, Malignant 1Osteosarcoma 1Neuroblastoma 1Head and Neck Neoplasms 1Gastrointestinal Neoplasms 1Esophageal 1Carcinoma, Hepatocellular 1Breast Neoplasms 1Brain Neoplasms 1Advanced Pancreatic Cancer 1Advanced Gastric Cancer 1Advanced Colorectal Cancer 1

Interventions

Oxaliplatin 5Capecitabine 5Paclitaxel 4apatinib 3Fluorouracil 3Docetaxel 3Cisplatin 3S 1 (combination) 2Leucovorin 2titanium silicide 1rucaparib 1relatlimab 1raltitrexed 1pazopanib 1olaparib 1linrodostat 1endostar protein 1durvalumab 1dacomitinib 1capivasertib 1camrelizumab 1Sunitinib 1SHR-1701 1Nivolumab 1Ipilimumab 1HMPL-013 1Epirubicin 1Doxorubicin 1CF regimen 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Advanced Gastric Cancer × endostar protein × Clear all
NCT00842491 2015-05-19

Study of Endostar With Cisplatin and Capecitabine as 1st Line Treatment in the Advanced Gastric Cancer

Peking University

Phase 2 Completed
45 enrolled
Gastrointestinal

Advanced Gastric Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡